Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Gangliosides for standardizing and increasing the sensitivity of cells to botulinum neurotoxins in in vitro test systems

Gangliosides for standardizing and increasing the sensitivity of cells to botulinum neurotoxins in in vitro test systems

US Patent 10921312 · Granted Feb 16, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cellular test systems for the determination of the biological activities of neur2020
Methods for enhancing the specific uptake of botulinum neurotoxins into cells2020
Methods for the determination of the biological activities of neurotoxin polypep2020
Cellular test systems for the determination of the biological activities of neur2018
Antibody that specifically binds partially processed or unprocessed neurotoxin p2018
Means and methods for manufacturing highly pure neurotoxin2016
Modified neurotoxins with poly-glycine and uses thereof2016
In vitro assay for quantifying clostridial neurotoxin activity2016
System for determining unprocessed and partially processed neurotoxin type A2015
System for determining unprocessed and partially processed neurotoxin type A2014